How Many MS Patients Use Cannabis Without a Prescription?

Credibility

Interest

Key Takeaway

Many people with MS in Italy are using cannabis without a prescription, often for medical reasons, and it seems to help with their symptoms.

What They Found

In a study of MS patients in Italy, about 15.5% reported using cannabis without a prescription. Most of these users said they used it to help with their symptoms like pain and muscle tightness, which are common in MS. Interestingly, many of them didn’t tell their doctors about this use, even though it seemed to help them feel better. Younger men and those who are single were more likely to use cannabis. Overall, the study suggests that unprescribed cannabis might be safe and could help reduce the need for other medications.

Who Should Care and Why

This information is important for MS patients and their caregivers because it highlights a common practice among people with MS. If cannabis can help manage symptoms like pain or muscle tightness, it might improve daily life for many. Caregivers can also play a role by discussing treatment options with patients, including the use of cannabis. Doctors should be aware of this trend to better understand their patients’ experiences and needs. Just like how some people find relief from headaches with herbal teas, others might find cannabis helpful for MS symptoms.

Important Considerations

The study focused only on patients in Italy, so the findings might not apply to all MS patients everywhere. Not everyone who uses cannabis may have the same experience, and some people might still face risks, even if they report benefits. It's important for patients to talk to their doctors about any treatments they are considering, including cannabis, to make the safest choices.

Categories:

Living with MS Specific Symptoms Nutrition

Article Topics:

CannabisCross-sectionalEpidemiologyMultiple sclerosis

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News